ArticleJournal of personalized medicine2022

Cost-Utility Analysis of Dupilumab for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Italy.

Eugenio De Corso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.